• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price

NSE: CAPLIPOINT

BSE: 524742

Small Cap

Healthcare Sector

₹2330.10

+82.70

(+3.68%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Caplin Point Laboratories Ltd Stock Performance

as on September 17, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹2,233.5
    ₹2,395
    downward going graph

    4.15%

    Downside

    2.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,599
    ₹2,641
    downward going graph

    31.38%

    Downside

    13.34%

    Upside

    downward going graph

Caplin Point Laboratories Ltd share price movements today

Previous Close
₹2,247.40
Open
₹2,247.40
Volume
4.98L
Upper Circuit
₹2,696.80
Lower Circuit
₹1,798.00
Day's Low - High
₹2,233.5 - ₹2,395
52 Week Low - High
₹1,599 - ₹2,641

Caplin Point Laboratories Ltd Historical Returns

1 Month Return
+ 4.45 %
3 Month Return
+ 8.06 %
1 Year Return
+ 11.93 %
3 Year Return
+ 211.34 %
5 Year Return
+ 293.56 %

Caplin Point Laboratories Ltd Fundamentals

as on September 17, 2025 at 4:01 pm IST

Market Cap

₹17,082.87 Cr

Return on Equity (ROE)

22.43

PE Ratio (TTM)

30.23

Return on capital employed (ROCE)

28.84

Industry PE ratio

42.14

Beta (LTM)

1.4

P/B Ratio

7.2

Dividend Yield

0.38

PEG Ratio

2.64

Quarterly Earnings Growth YOY

20.69

EPS (TTM)

60.75

Sector

Pharmaceuticals

Book Value

276.38

Technical Analysis

Bullish

View Technical Analysis

Caplin Point Laboratories Ltd Stock Valuation

as on September 17, 2025 at 4:01 pm IST

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (30.23x)

September 16, 2025

Industry (42.14x)

September 16, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 30.23x

Caplin Point Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Caplin Point Laboratories Ltd image
Caplin Point Laboratories Ltd
BUY17,082.8758.71%0.514611,694
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY37,900.9331.66%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY17,847.9713.24%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,667.27-3.72%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,761.6244.57%0.672441,515
See all

Analyst Recommendation on Caplin Point Laboratories Ltd Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2508

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share Price Target

Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.

What analysts predicted

11.6%UPSIDE

Target Price

₹2508

Current Price

₹2330.1

Analyzed by

2 Analysts

High

₹2516

Target

₹2508.00

Low

₹2500

Caplin Point Laboratories Ltd target price ₹2508, a slight upside of 11.6% compared to current price of ₹2330.1. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Stock's Interest Amongst Investors

Search interest for Caplin Point Laboratories Ltd Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Caplin Point Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
359.05
372.07
389.28
395.32
410.06
435.5
453.22
458.96
483.1
492.96
502.45
510.22
Other Income
16.48
14.16
11.48
12.12
20.54
17.2
17.35
18.58
20.77
31.36
25.82
23.17
Total Income
375.53
386.23
400.76
407.44
430.6
452.7
470.57
477.54
503.87
524.32
528.27
533.39
Expenses
253.48
262.7
265.33
268.79
272.66
293.22
307.99
307.15
318.44
330.68
334.39
332.46
Operating Profit
105.57
109.37
123.95
126.53
137.4
142.28
145.23
151.81
164.66
162.28
168.06
177.76
Operating Profit Margin %
29.4%
29.4%
31.84%
32.01%
33.51%
32.67%
32.04%
33.08%
34.08%
32.92%
33.45%
34.84%
Profit Before Interest, Tax and Depreciation
122.05
123.53
135.43
138.65
157.94
159.48
162.58
170.39
185.43
193.64
193.88
200.93
Interest
0.14
0.36
0.23
0.28
0.18
0.17
0.15
0.05
0.21
0.18
0.17
0.18
Depreciation
11.46
11.43
11.13
11.38
11.76
13.9
16.4
15.96
16.76
16.2
17.04
16.29
Profit Before Tax
110.45
111.74
124.07
126.99
146
145.41
146.03
154.38
168.46
177.26
176.67
184.46
Tax Paid
18.42
14.35
22.83
22.76
29.86
25.59
24.8
29.46
37.65
37.19
31.39
33.7
Profit After Tax
92.03
97.39
101.24
104.23
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
Total Net profit including share of profit / Loss from associate company
92.03
97.39
101.24
104.23
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
EPS
12.09
12.86
13.45
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
Actual EPS
12.09
12.86
13.45
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
Adjusted EPS
12.09
12.86
13.45
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
Diluted EPS
11.99
12.75
13.33
13.55
15.06
15.39
15.9
16.24
17.12
18.19
18.69
20.03

Caplin Point Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
401.65
539.84
648.69
863.2
1,061.29
1,269.41
1,466.73
1,694.1
1,937.47
Other Income
9.96
12.67
19.03
41.33
23.54
38.75
56.06
67.21
96.43
Total Income
411.6
552.51
667.72
904.53
1,084.83
1,308.16
1,522.79
1,761.31
2,033.9
Expenses
277.23
345.07
417.36
603.13
732.65
874.74
1,025.67
1,142.66
1,290.55
Operating Profit
124.42
194.77
231.33
260.07
328.64
394.67
441.06
551.44
646.92
Operating Profit Margin %
30.98%
36.08%
35.66%
30.13%
30.97%
31.09%
30.07%
32.55%
33.39%
Profit Before Interest, Tax and Depreciation
134.37
207.43
250.36
301.4
352.18
433.42
497.12
618.65
743.35
Interest
0.13
0.06
0.06
0.32
1.59
0.7
0.78
0.78
0.61
Depreciation
13.3
19
23.43
31.62
36.97
46.9
44.99
53.44
65.96
Profit Before Tax
120.94
188.37
226.87
269.46
313.62
385.82
451.35
564.43
676.78
Tax Paid
25.45
43.74
50.32
54.38
62.18
77.37
74.36
103.01
135.69
Profit After Tax
95.5
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
Total Net profit including share of profit / Loss from associate company
95.5
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
EPS
12.65
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
Actual EPS
12.65
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
Adjusted EPS
12.65
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
Diluted EPS
12.65
19.06
23.23
28.2
31.71
39.26
49.18
59.9
70.25

Caplin Point Laboratories Ltd Cash Flow

Figures in Rupees Crores

Jun 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
49.88
42.4
67.61
66.49
83.42
44.68
268.61
336.73
271.37
318.39
Cash Flow from Investing Activities
-22.66
-5.72
-36.1
-69.02
-99.74
-54.33
-29.68
-376.86
-216.4
-319.18
Cash Flow from Financing Activities
-8.67
-13.95
-6.75
-11.6
89.79
79.76
-23.98
-40.68
-28.17
-38.07
Net Cash Flow
18.55
22.73
24.76
-14.14
73.48
70.11
214.95
-80.81
26.8
-38.86

Caplin Point Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
68.8%
70.66%
70.63%
70.63%
70.62%
70.62%
70.56%
70.56%
70.56%
70.56%
70.56%
DII
1.12%
0.65%
0.26%
0.2%
0.43%
1.09%
1.49%
1.84%
2.11%
2.01%
2.22%
FII
0%
0%
0%
3.09%
2.85%
3.34%
3.37%
3.7%
4.86%
5.73%
6.17%
Public
27.84%
26.34%
26.42%
26.08%
26.1%
24.95%
24.57%
23.9%
22.47%
21.7%
21.05%
Total Outstanding Shares
7,58,92,246
7,59,02,746
7,59,33,746
7,59,39,746
7,59,41,746
7,59,41,746
7,60,10,296
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
Total Shareholders
82,687
82,146
78,956
78,068
79,438
81,409
80,411
96,123
92,702
96,387
94,169

Mutual Funds that own Caplin Point Laboratories Ltd Stock

Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 23.26% since last year same period to ₹152.80Cr in the Q1 2025-2026. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 7.18% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2025

    In the quarter ending June 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3.00 per share on 07 Aug 2025 - translating a dividend yield of 0.38%.

    Read More about Dividends

Indices Featuring Caplin Point Laboratories Ltd Stock

Check stock indices that include Caplin Point Laboratories Ltd.

BSE Healthcare

₹44,738.73

-0.08 (▲-37.44%)

S&P BSE 250 SmallCap

₹6,988.54

0.46 (▲32.27%)

Nifty Smallcap 250

₹17,470.75

0.51 (▲88.55%)

Nifty MidSmallcap 400

₹20,277.15

0.3 (▲60.35%)

BSE 500

₹36,813.13

0.32 (▲115.74%)

Nifty 500

₹23,445.20

0.32 (▲75.9%)

S&P BSE 400 MidSmallCap

₹12,291.60

0.29 (▲35.8%)

BSE Small-Cap

₹54,537.03

0.51 (▲276.99%)

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 15 quarters, 74.95 Cr → 152.8 Cr (in ₹), with an average increase of 4.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 20 quarters, 269.88 Cr → 533.39 Cr (in ₹), with an average increase of 3.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, CAPLIPOINT stock has moved up by 211.3%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.70% to 6.14% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.74% to 1.93% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.70% to 21.05% in Jun 2025 quarter

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹510.22Cr as on June 2025 (Q1 FY26)
Net Profit: ₹150.76Cr as on June 2025 (Q1 FY26)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

FAQs

What is Caplin Point Laboratories Ltd share price today?

Caplin Point Laboratories Ltd share price today stands at ₹2330.1 as on at the close of the market. Caplin Point Laboratories Ltd share today touched a day high of ₹2395 and a low of ₹2233.5.

What is the 52 week high and 52 week low range for Caplin Point Laboratories Ltd share?

Caplin Point Laboratories Ltd touched a 52 week high of ₹2641 and a 52 week low of ₹1599. Caplin Point Laboratories Ltd share price today i.e. is closed at ₹2330.1, which is -11.77% down from its 52 week high and 45.72% up from its 52 week low.

What is Caplin Point Laboratories Ltd's market capitalisation today?

Caplin Point Laboratories Ltd market capitalisation is ₹17,082.87 Cr as on .

How to buy Caplin Point Laboratories Ltd shares?

To buy Caplin Point Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CAPLIPOINT or Caplin Point Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Caplin Point Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Caplin Point Laboratories Ltd trading volume today?

Caplin Point Laboratories Ltd trading volume is 4.98L as on . This means that 4.98L shares of Caplin Point Laboratories Ltd were bought and sold on the stock market during today's trading session.